50
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Functional drug candidate profiling using complex human organotypic cell culture models: a promising way to reduce clinical drug failure

Pages 935-947 | Published online: 08 Aug 2007

Bibliography

  • MONTEITH GR, BIRD GS: Techniques: high-throughput measurement of intracellular Ca(2+) – back to basics. Trends Pharmacol. Sci. (2005) 26(4):218-223.
  • NEW DC, MILLER-MARTINI DM, WONG YH: Reporter gene assays and their applications to bioassays of natural products. Phytother. Res. (2003) 17(5):439-448.
  • HOHEISEL JD: Microarray technology: beyond transcript profiling and genotype analysis. Nat. Rev. Genet. (2006) 7(3):200-210.
  • STOLL D, TEMPLIN MF, BACHMANN J, JOOS TO: Protein microarrays: applications and future challenges. Curr. Opin. Drug Discov. Devel. (2005) 8(2):239-252.
  • ESPINA V, MEHTA AI, WINTERS ME, CALVERT V, WULFKUHLE J, PETRICOIN EF et al.: Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics (2003) 3(11):2091-2100.
  • EMING R,VISCONTI K, HALL F et al.: Humanized mice as a model for rheumatoid arthritis. Arthritis Res. (2002) 4(Suppl. 3):S133-S140.
  • ROZMAHEL R, GYOMOREY K, PLYTE S et al.: Incomplete rescue of cystic fibrosis transmembrane conductance regulator deficient mice by the human CFTR cDNA. Hum. Mol. Genet. (1997) 6(7):1153-1162.
  • MESTAS J, HUGHES CCW: Of mice and not men: differences between mouse and human immunology. J. Immunol. (2004) 172:2731-2738.
  • FEGHALI CA, WRIGHT TM: Cytokines in acute and chronic inflammation. Front. Biosci. (1997) 2:2-26.
  • SUNTHARALINGAM G, PERRY MR, WARD S et al.: Cytokine storm in a Phase I trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. (2006) 355(10):1018-1028.
  • ROME S, CLEMENT K, RABASA-LHORET R et al.: Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. J. Biol. Chem. (2003) 278(20):18063-18068.
  • ODA K, KITANO H: A comprehensive map of the toll-like receptor signaling network. Mol. Syst. Biol. (2006) [Epub ahead of print].
  • PING J, WANG E, PROVENZANO M et al.: Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets. J. Transl. Med. (2006) [Epub ahead of print].
  • CHEUNG VG, CONLIN LK, WEBER TM et al.: Natural variation in human gene expression assessed in lymphoblastoid cells. Nat. Genet. (2003) 33(3):422-425.
  • FITZPATRICK DR, WILSON CB: Methylation and demethylation in the resolution of genes, cell and responses in the immune system. Clin. Immunol. (2003) 109:37-45.
  • FAN J, HELLER NM, GOROSPE M et al.: The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. In: Series ‘Signalling and Transcriptional Regulation in Inflammatory and Immune Cells: Importance in Lung Biology and Disease’. Chung KF, Adcock IM (Eds), No. 1 in this Series.
  • HIRANI V, ANTONICELLI F, STRIETER RM et al.: The regulation of interlekin-8 by hypoxia in human macrophages – a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol. Med. (2001) 7(10):685-697.
  • CHRISTMAN JW, BLACKWELL TS, JUURLINK BJH: Redox regulation of NF-kB: therapeutic potential for attenuating inflammatory responses. Brain Pathol. (2000) 10:153-162.
  • BANK U, KüPPER B, REINHOLD D et al.: Evidence for a crucial role of neutrophil derivd serum proteases in the inactivation of interleukin-6 at sites of inflammation. FEBS Lett. (1999) 461:235-240.
  • REED CE, KITA H: The role of protease activation of inflammation in allergic respiratory diseases. J. Allergy Clin. Immunol. (2004) 114:997-1008.
  • MARIATHASAN S, WEIS DS, NEWTON K et al.: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 440(7081):228-232.
  • KANNEGANTI TD, OZOREN N, BODY-MALAPEL M et al.: Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature (2006) 440(7081):233-236.
  • MARTIN GR, WALLACE JL: Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp. Biol. Med. (2006) 231(2):130-137.
  • CARIO E, PODOLSKY DK: Intestinal epithelial TOLLerance versus InTOLLerance of commensals. Mol. Immunol. (2005) 42:883-893.
  • BISSET LR, SCHMID-GRENDELMEIER P: Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr. Opin. Pulm. Med. (2005) 11(1):35-42.
  • ALBANESI C, SCARSONI C, GIUSTIZIERI MC et al.: Keratinocytes in inflammatory skin disorders. Curr. Drug Targets Inflam. Allergy (2005) 4:329-334.
  • MALHOTRA S, PAUL MAN SF, SIN DS: Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin. Emerging Drugs (2006) 11(2):275-291.
  • SMALLEY KS, LIONI M, HERLYN M: Life isn't flat: taking cancer biology to the next dimension. In vitro Cell Dev. Biol. Anim. (2006) 42(8):242-247.
  • HALL HG, FARSON DA, BISSELL MJ: Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc. Natl. Acad. Sci. USA (1982) 79(15):4672-4676.
  • NELSON CM, VANDUIJN MM, INMAN JL, FLETCHER DA, BISSELL MJ: Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science (2006) 314(5797):298-300.
  • ANDL CD, MIZUSHIMA T, NAKAGAWA H et al.: Epidermal growth factor receptor mediates increased cell proliferation, migration and aggregation in esophageal keratinocytes in vitro and in vivo. J. Biol. Chem. (2003) 278(3):1824-1830.
  • TAKAKU M, WADA Y, JINNOUCHI K et al.: An in vitro coculture model of transmigrant monocytes and foam cell formation. Arterioscler. Thromb. Vasc. Biol. (1999) 19(10):2330-2339.
  • OLSNES C, HEIMDAL J-H, KROSS K, OLOFSSON J, AARSTAD HJ: Mechanisms for monocyte activation in co-culture with autologous tumor spheroids. Cell. Immunol. (2002) 219(1):11-21.
  • DIETZE D, KOENEN M, ROHRIG K, HORIKOSHI H, HAUNER H, ECKEL J: Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes (2002) 51(8):2369-2376.
  • HSIEH FH, SHARMA P, GIBBONS A, GOGGANS T, ERZURUM SC, HAQUE SJ: Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells. Proc. Natl. Acad. Sci. USA (2005) 102(40):14380-14385.
  • TAO F, KOBZIG L: Lung macrophage-epithelial cell interactions amplify particle-mediated cytokine release. Am. J. Respir. Cell Mol. Biol. (2002) 26(4):499-505.
  • CARROL MC: The complement system in regulation of adaptive immunity. Nat. Immunol. (2004) 5(10):981-986.
  • TRAPANI JA, SMYTH MJ: Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. (2002) 2:735-747.
  • KOWALSKI J, BARYLSKI M, BANACH M et al.: Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. J. Cardiovasc. Pharmacol. (2006) 48(4):143-147.
  • HALLER D, JOBIN C: Interaction between resident luminal bacteria and the host. Can a healthy relationship turn sour? J. Pediat. Gastroenterol. Nutr. (2004) 38:123-136.
  • ESTEVE E, RICART W, MANUEL J et al.: Dislipidemia and inflammation – an evolutionary conserved mechanism. Clin. Nutr. (2005) 24:16-31.
  • JENSEN LE, WHITEHEAD AS: Review article: regulation of serum amyloid A protein expression during the acute phase response. Biochem. J. (1998) 334:489-503.
  • KEMPER C, ATKINSON JP: T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. (2007) 7:9-18.
  • HAMBURGER SA, MCEVER RP: GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood (1990) 75(3):550-554.
  • DANESE S, De LA MOTTE C, Reyes BMR et al.: Cutting edge: T-cells trigger CD40 dependent platelet activation and granular RANTES release. A novel pathway for immune response amplification. J. Immunol. (2004) 172:2011-2015.
  • McGEE J, FITZPATRICK F: Enzymatic hydration of leukotriene A4. purification and characterization of a novel epoxide hydrolase from human erythrocytes. J. Biol. Chem. (1985) 260(23):12832-12837.
  • MURDOCH C, FINN A: Chemokine receptors and their role in inflammation and infectious diseases. Blood (2000) 95:3032-3043.
  • FONSECA F, PORTO C, UCHIDA K et al.: Red blood cells inhibit activation induced cell death and oxidative stress in human peripheral blood leukocytes. Blood (2001) 97:3152-3160.
  • TROELSTA A, de GRAAF-MILTENBURG C, VAN BOMMEL T et al.: Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is via CD11b/CD18. J. Immunol. (1999) 162:4220-4225.
  • ZABEL BA, ZUNIGA L, OHYAMA T et al.: Chemoattractants, extracellular proteases, and the integrated host defense response. Exp. Hematol. (2006) 34(8):1021-1032.
  • BANK U, ANSORGE S: More than destructive – neutrophil derived serine proteases in cytokine bioactivity control. J. Leuk. Biol. (2001) 69(2):197-206.
  • ELLIS TN, BEAMAN BL: Interferonγ activation of polymorphonuclear neutrophil function. Immunology (2004) 112:2-12.
  • BROOKS P, EMERY P, EVANS JF et al.: Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) (1999) 38(8):779-788.
  • GERARDS AH, De LATHOUDER S, De GROOT ER, DIJKMANS BA, AARDEN LA: Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology (Oxford) (2003) 42:1189-1196.
  • CARIO E, GERKEN E, PODOLSKY DK: “For whom the bell tolls?” – innate defense mechanisms and survival strategies of the intestinal epithelium against luminal pathogens. Z. Gastroenterol. (2002) 40:983-990.
  • HIDALGO IJ, RAUB TJ, BORCHARDT RT: Characterization of the human colon carcinoma cell line Caco-2 as a novel system for intestinal epithelial permeability. Gastroenterology (1989) 96:736-749.
  • HALTNER E, SCHMITZ S, GUIDORF C, RUOFF J: In vitro permeabilitätsuntersuchungen als ersatz für tier-und humanstudien – welche voraussetzungen müssen erfüllt sein? ALTEX (2000) 18:81-87.
  • RESTA-LEHNERT S, BARRETT KE: Probiotics and commensals reverse TNF-α and IFN-γ induced dysfunction in human intestinal epithelial cell lines. Gastroenterology (2006) 130:731-746.
  • WEISS B, ZIMMERMANN K, SCHMOLZ M: A novel co-culture system consisting of differentiated human gut epithelium and human whole-blood cultures allows the combined investigation of absorption and immuno-pharmacology of test substances. Poster Presentation at the Falk Symposium: Mechanisms in Inflammatory Bowel Diseases. Berlin, Germany (2003).
  • WEISS B, SCHMOLZ M: Immuno-modulatory effects of intestinal samples in a novel gut epithelium/whole-blood co-culture system (“EDI-Co gut”). Poster Presentation at the 4th NIZO Dairy Conference. Papendal, The Netherlands (2005).
  • WELK M, SCHMOLZ M: A new human organotypical model for immuno-pharmacological research in dermatology: EDI-Co skin. Poster Presentation on the 9th International Conference and Exhibition on Drug Discovery. Basel, Switzerland (2005).
  • FREITAS M, TAVAN E, CAYUELA C, DIOP L, SAPIN C, TRUGNAN G: Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol. Cell (2003) 95(8):503-506.
  • BAYER H, MüLLER T, MYRTEK D et al.: Serotoninergic receptors on human airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. (2007) 36:85-93.
  • OEI E, KALB T, BEURIA P et al.: Accessory cell functions of airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. (2004) 287:L318-L331.
  • HIPPENSTIEL S, OPITZ B, SCHMECK B et al.: Lung epithelium as a sentinel and effector system in peumonia – molecular mechanisms of pathogen recognition and signal transduction. BMC Resp. Res. (2006) 7:97.
  • BALLOW M: Biologic immune response modifiers: trials and tribulations – are we there yet? J. Allergy Clin. Immunol. (2006) 118:1209-1215.
  • HOFFMANN JC, PAWLOWSKI NN, KüHL AA, HöHNE W, ZEITZ M: Animal models of inflammatory bowel disease: an overview. Pathobiology (2002) 70:121-130.
  • MACDONALD TT: The mucosal immune system. Parasite Immunol. (2003) 25:235-246.
  • FRODE TS, MEDEIROS TS: The puzzle of asthma treatment: animal models to genetic studies. Curr. Pharm. Des. (2005) 11(19):2515-2524.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.